TetraLogic Pharmaceuticals Corp TLOG Stock Analysis
- PINK
- Stock
- Market closed · opens Monday 9:30 AM ET
$0.00 unchanged at close Oct 13
Last close · Previous close $0.00
- Market cap
- At the Oct 13 close
- P/E ratio
- On last 12 months’ EPS
- Diluted EPS
- Last 12 months
- Dividend yield
- Last 12 months
Price chart
$0.00unchangedTue, Oct 13 session
Use the left and right arrow keys to move along the chart.
Price data
Trading
- Previous close$0.00Oct 12
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
Performance
Valuation
Financials
Dividends
About TetraLogic Pharmaceuticals Corp
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. Its clinical-stage product candidate, Birinapant, is in Phase II clinical trial administered with azacitidine for the treatment of myelodysplastic syndromes. The companys pre-clinical programs also comprise Phase I/II open-label, non-randomized clinical trial of Birinapant administered with conatumumab in third-line ovarian cancer; and Phase I clinical trial of Birinapant in subject with chronic Hepatitis B virus. In addition, its clinical-stage product candidate, suberohydroxamic acid 4-methoxycarbonyl phenyl ester, is in Phase II clinical trial for the treatment of early-stage cutaneous T-cell lymphoma. The company has collaboration with Amgen, Inc. for exploring the combination of Birinapant administered with Amgens TRAIL receptor agonist antibody, conatumumab. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
- Sector
- Industry
- Headquarters
- Exchange
- PINK
- Asset type
- Common stock
- Price history since
TLOG news
Explore more stocks
Prices are from the last refresh. Open any stock for its live dashboard.
Popular stocks
TLOG stock FAQ
What is TLOG stock’s price today?
TetraLogic Pharmaceuticals (TLOG) traded at $0.00 at the close on , unchanged from the previous close of $0.00.
What exchange does TLOG trade on?
TetraLogic Pharmaceuticals trades on the PINK under the ticker symbol TLOG. Its price history on this dashboard begins on .
Member SIPC.Low CommissionsLearn More (opens in a new tab)Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.
About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.
This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).
The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.